Knowledge | Ovarian Hyperstimulation Syndrome Explained: A Complication Women Undergoing IVF Should Watch For
Ovarian hyperstimulation syndrome (OHSS) is a common but potentially serious complication of assisted reproductive treatment, particularly among women receiving injectable ovarian stimulation medication for in vitro fertilization (IVF). According to a recent WebMD medical article reviewed by obstetrician-gynecologist Traci C. Johnson, the syndrome is triggered by abnormally elevated levels of human chorionic gonadotropin (HCG). Without prompt treatment, it can lead to severe or even fatal consequences.
What causes OHSS: HCG is the main trigger
The core mechanism of OHSS is an excessive ovarian response to hormones, especially **human chorionic gonadotropin (HCG)**. HCG is secreted by placental cells early after embryo implantation and can normally be detected in the blood one week into pregnancy. In ovarian stimulation treatment, however, HCG is injected to promote follicle maturation and ovulation at doses much higher than natural physiological levels.
In some women, HCG causes an abnormal ovarian response, including swelling, fluid accumulation, and leakage, leading to a range of clinical symptoms. Oral medications rarely cause OHSS; injectable medications are the primary trigger.
Symptom severity: From bloating to breathing difficulty, early recognition matters
OHSS symptoms vary by severity. Common symptoms of mild OHSS include:
Weight gain
Abdominal bloating
Lower abdominal pain or discomfort
Nausea, vomiting, and diarrhea
Tenderness around the ovaries
If OHSS progresses to a severe form, symptoms may include:
Rapid weight gain (more than 1 kilogram per day)
Difficulty breathing
Significantly reduced urine output
Increased risk of blood clots
The author advises seeking immediate medical care if any of these severe symptoms occur. Early intervention can greatly reduce complications.
Diagnosis: Ultrasound and blood tests are key
If a woman receiving fertility treatment develops possible OHSS symptoms, a doctor will usually arrange the following tests:
Physical examination: Checks for increased abdominal circumference, weight changes, and ovarian tenderness. Daily self-weighing may help detect abnormalities early.
Imaging (ultrasound/X-ray): Evaluates significant ovarian enlargement and fluid leakage into the abdomen or chest, helping determine disease severity.
Blood tests: Assess hormone levels, kidney function, and electrolyte imbalance. Routine testing can help screen for potential problems early during treatment such as IVF.
Treatment depends on severity
OHSS treatment generally falls into two categories based on severity:
Mild OHSS: Symptom relief and monitoring
Drink plenty of water (1.5–2 liters daily is recommended)
Avoid strenuous activity and rest as needed
Use over-the-counter pain medication as directed by a doctor
Weigh yourself daily to monitor changes
Avoid caffeine and alcohol
Symptoms usually resolve on their own within two weeks without hospitalization or invasive treatment.
Severe OHSS: Hospitalization may be required
Intravenous (IV) fluids
Medication to relieve symptoms
Medication to suppress ovarian activity
Needle drainage if abdominal fluid accumulation is severe
Early intervention is essential and can significantly reduce complications.
Prevention: An individualized fertility plan is key
OHSS can be prevented, particularly with the following strategies:
Adjust HCG to the lowest effective dose
Add medication that suppresses the ovarian response, such as a GnRH antagonist
Pause injectable medication to allow hormone levels to fall naturally
Use an alternative to HCG, such as Lupron to trigger ovulation
Freeze eggs or embryos and delay transfer to allow the ovaries time to recover
Doctors usually tailor treatment to the individual patient to prevent OHSS at its source.
Risk warning: OHSS can be fatal and must be taken seriously
Extensive fluid leakage causing dehydration and electrolyte imbalance
Blood clots in the legs or lungs, which may be life-threatening
The author therefore emphasizes: awareness + medical intervention = greater safety. Seek immediate medical care during ovarian stimulation if you experience:
Shortness of breath or difficulty breathing
Severe abdominal pain
Inability to eat or persistent vomiting
Daily weight gain of more than 2 pounds (about 1 kilogram)
Knowledge | Ovarian hyperstimulation syndrome: An IVF complication women should know
Knowledge | Ovarian Hyperstimulation Syndrome Explained: A Complication Women Undergoing IVF Should Watch For
Ovarian hyperstimulation syndrome (OHSS) is a common but potentially serious complication of assisted reproductive treatment, particularly among women receiving injectable ovarian stimulation medication for in vitro fertilization (IVF). According to a recent WebMD medical article reviewed by obstetrician-gynecologist Traci C. Johnson, the syndrome is triggered by abnormally elevated levels of human chorionic gonadotropin (HCG). Without prompt treatment, it can lead to severe or even fatal consequences.
What causes OHSS: HCG is the main trigger
The core mechanism of OHSS is an excessive ovarian response to hormones, especially **human chorionic gonadotropin (HCG)**. HCG is secreted by placental cells early after embryo implantation and can normally be detected in the blood one week into pregnancy. In ovarian stimulation treatment, however, HCG is injected to promote follicle maturation and ovulation at doses much higher than natural physiological levels.
In some women, HCG causes an abnormal ovarian response, including swelling, fluid accumulation, and leakage, leading to a range of clinical symptoms. Oral medications rarely cause OHSS; injectable medications are the primary trigger.
Symptom severity: From bloating to breathing difficulty, early recognition matters
OHSS symptoms vary by severity. Common symptoms of mild OHSS include:
Weight gain
Abdominal bloating
Lower abdominal pain or discomfort
Nausea, vomiting, and diarrhea
Tenderness around the ovaries
If OHSS progresses to a severe form, symptoms may include:
Rapid weight gain (more than 1 kilogram per day)
Difficulty breathing
Significantly reduced urine output
Increased risk of blood clots
The author advises seeking immediate medical care if any of these severe symptoms occur. Early intervention can greatly reduce complications.
Diagnosis: Ultrasound and blood tests are key
If a woman receiving fertility treatment develops possible OHSS symptoms, a doctor will usually arrange the following tests:
Physical examination: Checks for increased abdominal circumference, weight changes, and ovarian tenderness. Daily self-weighing may help detect abnormalities early.
Imaging (ultrasound/X-ray): Evaluates significant ovarian enlargement and fluid leakage into the abdomen or chest, helping determine disease severity.
Blood tests: Assess hormone levels, kidney function, and electrolyte imbalance. Routine testing can help screen for potential problems early during treatment such as IVF.
Treatment depends on severity
OHSS treatment generally falls into two categories based on severity:
Mild OHSS: Symptom relief and monitoring
Drink plenty of water (1.5–2 liters daily is recommended)
Avoid strenuous activity and rest as needed
Use over-the-counter pain medication as directed by a doctor
Weigh yourself daily to monitor changes
Avoid caffeine and alcohol
Symptoms usually resolve on their own within two weeks without hospitalization or invasive treatment.
Severe OHSS: Hospitalization may be required
Intravenous (IV) fluids
Medication to relieve symptoms
Medication to suppress ovarian activity
Needle drainage if abdominal fluid accumulation is severe
Early intervention is essential and can significantly reduce complications.
Prevention: An individualized fertility plan is key
OHSS can be prevented, particularly with the following strategies:
Adjust HCG to the lowest effective dose
Add medication that suppresses the ovarian response, such as a GnRH antagonist
Pause injectable medication to allow hormone levels to fall naturally
Use an alternative to HCG, such as Lupron to trigger ovulation
Freeze eggs or embryos and delay transfer to allow the ovaries time to recover
Doctors usually tailor treatment to the individual patient to prevent OHSS at its source.
Risk warning: OHSS can be fatal and must be taken seriously
Severe OHSS complications include:
Excessive abdominal pressure compressing internal organs
Extensive fluid leakage causing dehydration and electrolyte imbalance
Blood clots in the legs or lungs, which may be life-threatening
The author therefore emphasizes: awareness + medical intervention = greater safety. Seek immediate medical care during ovarian stimulation if you experience:
Shortness of breath or difficulty breathing
Severe abdominal pain
Inability to eat or persistent vomiting
Daily weight gain of more than 2 pounds (about 1 kilogram)
Dizziness or significantly reduced urine output
Story source:
Collected online